| Predicate |
Object |
| contentType |
Comparative Study|Journal Article|Research Support, Non-U.S. Gov't|Review |
| endingPage |
111 |
| issn |
1073-449X
1535-4970 |
| issueIdentifier |
2 |
| pageRange |
109-111 |
| publicationName |
American Journal of Respiratory and Critical Care Medicine |
| startingPage |
109 |
| bibliographicCitation |
Pack AI. Should a pharmaceutical be approved for the broad indication of excessive sleepiness? Am J Respir Crit Care Med. 2003 Jan 15;167(2):109–11. doi: 10.1164/rccm.2211007. PMID: 12524251. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_398b353b87f7055f52ab29a625135310 |
| date |
2003-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/12524251
https://doi.org/10.1164/rccm.2211007 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1535-4970
https://portal.issn.org/resource/ISSN/1073-449X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8469 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Should a Pharmaceutical Be Approved for the Broad Indication of Excessive Sleepiness? |
| discusses |
http://id.nlm.nih.gov/mesh/M0002345
http://id.nlm.nih.gov/mesh/M0001063
http://id.nlm.nih.gov/mesh/M0140282 |
| hasPrimarySubjectTerm |
http://id.nlm.nih.gov/mesh/D017277
http://id.nlm.nih.gov/mesh/D001559Q000627
http://id.nlm.nih.gov/mesh/D000697Q000627
http://id.nlm.nih.gov/mesh/D006970Q000188 |
| hasSubjectTerm |
http://id.nlm.nih.gov/mesh/D014481
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D012891Q000175
http://id.nlm.nih.gov/mesh/D001559Q000494
http://id.nlm.nih.gov/mesh/D000077408
http://id.nlm.nih.gov/mesh/D014486
http://id.nlm.nih.gov/mesh/D012680
http://id.nlm.nih.gov/mesh/D006970Q000175
http://id.nlm.nih.gov/mesh/D012891Q000188
http://id.nlm.nih.gov/mesh/D017286
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000697Q000494
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D018570 |